5:53 PM
 | 
Jul 12, 2012
 |  BC Extra  |  Financial News

Merck gains on odanacatib osteoporosis data

Merck & Co. Inc. (NYSE:MRK) gained $5.2 billion in market cap on Thursday after reporting late Wednesday that...

Read the full 75 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >